Structure Therapeutics Newsroom

Cantor Fitzgerald Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $65

Moomoo NewsAug 15 08:31 ET · Ratings

Express News | Cantor Fitzgerald Reiterates Overweight on Structure Therapeutics, Maintains $65 Price Target

BenzingaAug 15 08:21 ET

Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and AbSci (ABSI)

TipRanksAug 15 08:00 ET · Ratings

Buy Rating Affirmed for Structure Therapeutics on Strong Pipeline and Undervalued Patent Portfolio

TipRanksAug 13 09:57 ET · Ratings

Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.

Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.

Zhitong FinanceAug 13 02:52 ET

Don't Forget This Startup's Weight-Loss Pill, Analyst Says -- Barrons.com

Barron'sAug 12 16:08 ET · Ratings

Structure Therapeutics (NASDAQ:GPCR) Is In A Good Position To Deliver On Growth Plans

Simply Wall StAug 11 10:55 ET

Express News | JMP Securities Maintains Market Outperform on Structure Therapeutics, Lowers Price Target to $86

BenzingaAug 9 14:41 ET

Structure Therapeutics Analyst Ratings

BenzingaAug 9 14:40 ET · Ratings

Structure Therapeutics Reports Q2 Results

Seeking AlphaAug 9 06:31 ET

Promising Outlook for Structure Therapeutics With Strong Pipeline and Financial Stability

TipRanksAug 9 00:26 ET

Why Are Hedge Funds Bullish on Structure Therapeutics Inc. (GPCR) Now?

Yahoo FinanceAug 8 20:18 ET

S&P rises over 2%, the best in nearly two years, with chip stocks up about 7%, Nasdaq and Chinese stocks up 2.8%, and US Treasury yields and the yen falling for three consecutive days.

The latest employment data alleviates concerns over the US economy, and US stocks rose more than 1.7%. Nvidia's stock rose more than 6%, and Tesla, Alibaba, PDD Holdings, and Tencent ADR rose more than 3%. Bullish on weight loss drug reports, Eli Lilly and Co's stock rose more than 13%, and Novo-Nordisk A/S's US stock rose nearly 8%. The 10-year US Treasury yield rose above 4%, and short-term bond yields rose by 10 basis points. Oil prices rose for the third consecutive day, gold halted its five-day decline, and digital currency had a big increase.

wallstreetcnAug 8 18:45 ET

Express News | Structure Therapeutics Q2 EPS $(0.18) Beats $(0.23) Estimate

BenzingaAug 8 17:20 ET

Express News | Structure Therapeutics : Cash Balance of $927.1 Mln Expected to Fund Projected Operations and Key Clinical Milestones Through at Least 2027

ReutersAug 8 16:41 ET

Express News | Structure Therapeutics Inc: Obesity Pipeline Consists of Four Oral Small Molecule Programs Targeting GLP-1, Gip, Amylin and Apj Receptors

ReutersAug 8 16:41 ET

Express News | Structure Therapeutics : Oral Small Molecule Amylin Receptor Agonist Development Candidate Expected to Be Selected in Q4 of 2024

ReutersAug 8 16:40 ET

Structure Therapeutics | 10-Q: Q2 2024 Earnings Report

SEC announcementAug 8 16:40 ET · Announcements

Express News | Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

ReutersAug 8 16:05 ET

Express News | Structure Therapeutics Inc. Q2 Net Income USD -26.034 Million

ReutersAug 8 16:05 ET